Clinical trial · Observational
Spectral Diagnosis of Cutaneous Malignancy
NCT00476905CI-TRIAL-00038706completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical research study is to evaluate the use of an imaging technology called spectral diagnosis. Researchers want to find out if a special spectral-diagnosis probe can be used to detect skin cancers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Spectral Diagnosis Probe | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Spectral-Diagnosis
- description
- Method for noninvasive detection of cutaneous malignancies
- interventionNames
- Device: Spectral Diagnosis Probe
Primary outcomes (1)
- measure
- Spectroscopic features of skin lesions in vivo
- timeFrame
- Preparing lesion, imaging it, and collecting the light signals should take about 10-15 minutes per lesion.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male or Female and over 18 years of age. 2. Patients undergoing an examination of their skin 3. Patients with a lesion(s) in one of the five categories: basal cell carcinoma, squamous cell carcinoma, pre-cancer lesions, pigmented lesions, and benign lesions 4. Patients whose lesion also warrants a biopsy. 5. Signed informed consent document. Exclusion Criteria: 1. Patients with absence of skin lesion(s) in one of the five categories. 2. Patients whose identified lesion did not need a biopsy. 3. Patients who did not sign the informed consent and agree to participate.
References
Publications (0)
Data not yet available
No reference posted for this study.